Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer Final Analysis of the HannaH Phase 3 Randomized Clinical Trial

Jackisch, C; Stroyakovskiy, D; Pivot, X; Ahn, JS; Melichar, B; Chen, SC; Meyenberg, C; Al-Sakaff, N; Heinzmann, D; Hegg, R

Jackisch, C (reprint author), Sana Klinikum Offenbach GmbH, Dept Obstet & Gynecol, Starkenburgring 66, D-63069 Offenbach, Germany.

JAMA ONCOLOGY, 2019; 5 (5):

Abstract

IMPORTANCE Confirmation of long-term comparability between subcutaneous and intravenous trastuzumab is essential. OBJECTIVE To evaluate efficacy and s......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索